BIT' s 10th Anniversary of Protein & Peptide Conference (PepCon-2017)
★ Scientific Program

The Conference Program is not in its final version, adjustments will occur. Final program will be issued in early March, 2017. 

 

Keynote Forum Parallel Forums
Stream 1 Stream 2 Stream 3 Stream 4 Stream 5 Stream 6 Stream 7

 

Stream 4: Latest Breakthrough of Protein and Peptide Based Drug Discovery



Session 401: Emerging Biomarkers and Targets Discovery and Validations

Time: Day 1, Afternoon, March 22, 2017
Place: Fukuoka, Japan
Chair Call for Chair
13:30-13:35 Chair's Introduction
13:35-14:00 Title: TBD
Dr. Yanping Zhang, Professor, The University of North Carolina at Chapel Hill, USA
14:00-14:25

Title: Cell-free Synthesized Membrane Proteins, A New Tool in Antibody Development and Drug Discovery
Dr. Hiroyuki Takeda, Associate Professor, Ehime University, Japan

14:25-14:50 Title: Functional Consequences of the Changes of Paraoxonase 1 (PON1) Activity, PON1 Expression and Protein N-homocysteinylation in Bisphosphonates-Treated Rats
Dr. Marta Rusek, Medical University of Lublin, Poland
14:50-15:15 Speech Opportunity Available, Apply Here
Abstract and Biography:
 Submit Here
15:15-15:30 Coffee Break


Session 402: Protein Kinases as Drug Targets

Time: Day 2, Morning, March 23, 2017
Place: Fukuoka, Japan
Chair Call for Chair
08:30-08:35 Chair's Introduction
08:35-09:00 Title: TBD
Dr. Rune Linding, University of Copenhagen, Denmark
09:00-09:25 Title: The Potential of Targeting Centrosome Kinase In Cancer Therapy
Dr. Yick Pang Ching, Assistant Professor, The University of Hong Kong, Hong Kong, China
09:25-09:50 Title: TBD
Dr. Jianxin Yu, Central Research Institute, Shanghai Pharmaceuticals Holding, China
09:50-10:15 Speech Opportunity Available, Apply Here
Abstract and Biography: Submit Here
10:15-10:30 Coffee Break


Session 403: Current and Potential Cancer Protein Targets

Time: Day 2, Afternoon, March 23, 2017
Place: Fukuoka, Japan
Chair Call for Chair
13:30-13:35 Chair's Introduction
13:35-14:00 Title: TBD
Dr. Steven Tucker, Institute of Medical Sciences, UK
14:00-14:25 Title: TBD
Dr. Ming-Shi Chang, Chair Professor, National Cheng-kung University,Taiwan
14:25-14:50 Title: Beyond the Reductionism: New Cancer Targets in Patient-derived Complex Models
Dr. Alessandro Carugo, Department of Genomic Medicine, MD Anderson Cancer Center, USA
14:50-15:15

Speech Opportunity Available, Apply Here
Abstract and Biography:
 Submit Here

15:15-15:30 Coffee Break
15:30-15:55

Title: Bladder Cancer Targeting Glycol Chitosan Nanoparticles With Ferrimagnetic Iron Oxide Nanocubes for NIRF-MR Dual-modality in Vivo Imaging
Dr. Jaehong Key, Assistant Professor, Yonsei University, South Korea

15:55-16:20

Title: TBD
Dr. Cosme E. Santiesteban-Toca, Tel Aviv Sourasky Medical Center, Israel


Session 404: New Protein/Peptide Drug Discovery and Design

Time: Day 3, Morning, March 24, 2017
Place: Fukuoka, Japan
Chair
Dr. Dongmei Wu, Professor, Chonbuk National University, South Korea
08:30-08:35
Chair's Introduction
08:35-09:00
Title: Kinins and Kinin Receptors in Acute and Chronic Inflammatory Lung Diseases
Dr. Dongmei Wu, Professor, Chonbuk National University, South Korea
09:00-09:25
Title:  Design and Clinical Application of SOLNATIDE, A New Peptide for Treatment of Critical Pulmonary Dysfunctions
Dr. Bernhard Fischer, CEO, Apeptico, Austia
09:25-09:50
Title: Development of Orally Bioavailable Peptide Macrocycle Therapeutics
Dr. Xudong Kong, Ecole Polytechnique Federale de Lausanne, Switzerland
09:50-10:15

Speech Opportunity Available, Apply Here
Abstract and Biography:
 Submit Here

10:15-10:30
Coffee Break
10:30-10:55

Title: Advances in Fusion Protein or Peptide Drug Research
Dr. Hanmei Xu, Professor, Pharmaceutical University China, China

10:55-11:20 Title: AP25 Recruits Integrin ΑVΒ3 and Α5Β1 to Lipid Rafts and Biphasically Regulates HUVEC Migration
Dr. Jiang Hu, Professor, China Pharmaceutical University, China
11:20-11:45

Title: Design, Synthesis and Simulation of Histone Deacetylase Inhibitors
Dr. Xiaohui Li, Associate Professor, Dalian University of Technology, China


Session 405: Delivery Technologies of Protein Drugs

Time: Day 3, Afternoon, March 24, 2017
Place: Fukuoka, Japan
Chair
Dr. Jason Z. Huang, Sr. Research Investigator II, Bristol-Myers Squibb Company, USA

 

 

Hosting Organization

whtslogo.JPG
World High-Tech Society

Operating Organization

BIT Group Global Ltd.

Supporting Organizations

logo01.png

logo02.png

Official Travel Agency

BIT World Travel Service, Inc.

Overseas Cooperate Medias and Journals
Previous Conferences
BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-0411-84799609-816, Fax: 0086-411-84799629
Copyright © 2016-2017 BIT Group Global Ltd.